A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
2.31 +0.01 (0.43%) SVNT

Click Here to Receive Instant E-mail and RSS Alerts


Trade SVNT now with

Stock Details

Last Trade:2.31 Change:+0.01 (0.43%) Prev Close:2.30 Open: 2.31 Days Range:2.28 – 2.33 52 Week Range: 2.04 - 11.91 Volume:887831 P/E: N/A
EPS:-1.00

Member Comments

No member comments available for SVNT


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/10/12

Recent Alert on 02/02/12 at 1:46pm
Jefferies Maintains an 'Underperform' on Savient Pharmaceuticals (SVNT); CEO Resigns After Short Tenure

Jefferies maintains an 'Underperform' on Savient Pharmaceuticals (NASDAQ: SVNT) price target cut from $2 to $1. Jefferies analyst says, "Departure of CEO, John Johnson, underscores a lack of clear strategy/limited Krystexxa potential. On... Read More

Recent Alert on 02/01/12 at 1:39pm
Unusual 11 Midday Movers 02/01: (KTCC) (MGAM) (COCO) (SGMO) Higher; (HVB) (JDAS) (IXYS) Lower
Recent Alert on 02/01/12 at 10:53am
Morning Movers 02/01: (COCO) (MGAM) (KTCC) (RSYS) Higher; (IXYS) (JDAS) (KWK) Lower
Recent Alert on 02/01/12 at 10:15am
Cowen Downgrades Savient Pharmaceuticals (SVNT) to Neutral
Recent Alert on 02/01/12 at 6:37am
Savient Pharma (SVNT) Appoints David Norton as CEO, Louis Ferrari as N.A. EVP

View AllRecent Press Releases

Press Release on 02/08/12 at 4:05pm
Savient Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
Press Release on 02/07/12 at 4:15pm
Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2011 Financial Results Conference Call on Monday, February 27, 2012

View AllRecent SEC Filings

SEC Filing on 02/08/12 at 2:50pm
Form SC 13G/A SAVIENT PHARMACEUTICALS Filed by: Capital Research Global Investors

View AllRecent Blog Posts

Blog Posts on 02/08/12 at 4:18am
4 Biotech Takeover/LBO Targets Hedge Funds Are Buying Up
Blog Posts on 02/07/12 at 10:13am
3 Stocks With High Short Interest: 1 Buy, 2 Sells
Blog Posts on 02/02/12 at 3:50pm
Departure Of CEO From Savient Is Disturbing, But I Retain My Rating On The Stock
Blog Posts on 01/30/12 at 10:58am
7 Best-Performing, Heavily Traded Biotechs Of The Year Under $10
Blog Posts on 01/25/12 at 4:02pm
2011 Review And Outlook For Biotechnology In 2012